.
Set delivery address
Change
Set delivery address
Change

Skinoren

Acne Gel 30g

Schedule  1  product : ID: 937445
Add to favourites

Skinoren Gel 30g contains active ingredients including AzelaicAcid.

Clicks - pharmacy collection

Pharmacy collection

This product is available for collection at a Clicks pharmacy only.

Clicks - dispensed by pharmacist

Dispensed by pharmacist

Dispensed at the professional discretion of a Clicks Pharmicist

Find in-store

See if we have this item in your closest store

R 353.00
eB: 3530

Delivered in 2 - 4 working days.

Please sign in to your online account to order OTC medication

Scheduled medicine. Sign in to order.

Medical aid prices may differ from the cash price displayed.

Any questions? Visit our OTC FAQ page for more information.

Clicks - pharmacy collection
pharmacy collection

This product is available for collection at a Clicks pharmacy only.

Clicks - dispensed by pharmacist
dispensed by pharmacist

Dispensed at the professional discretion of a Clicks Pharmicist

Otc Product Info

More Information

Detailed information

Description:
Skinoren Skin Health Skinoren Acne Gel 30

Detailed Description:
1g contains:0.15g micronised azelaic acid.0.1% (m/m) benzoic acid.Scheduling status:Proprietary name and dosage form:Skinoren gel.Composition:1g Skinoren gel contains 150 mg azelaic acid. Excipients: propylene glycol, polysorbate 80, lecithin, carbopol 980, triglycerides: medium chain, sodium hydroxide, disodium edetate, benzoic acid and purified water.Pharmacological classification:A 13.12 acne preparations.Pharmacological action:Pharmacodynamic properties:The antimicrobial action of azelaic acid and a direct influence on follicular hyperkeratosis are assumed to be the basis for the therapeutic efficacy of Skinoren gel in acne.Clinically, a significant reduction in the colonisation density of Propionibacterium acnes and a significant reduction in the fraction of free fatty acids in the skin surface lipids is observed.In vitro and in vivo, azelaic acid inhibits the proliferation of keratinocytes and normalises the disturbed terminal epidermal differentiation processes in acne. In the rabbit ear model azelaic acid accelerates the comedolysis of tetradecane-induced comedones.The mechanism by which azelaic acid interferes with the pathogenic events in rosacea is unknown. Several in vitro and ex vivo investigations indicate that azelaic acid may exert an anti-inflammatory effect by reducing the formation of pro-inflammatory, reactive oxygen species.Pharmacokinetic properties:Azelaic acid penetrates into all layers of the skin after topical application of the gel. Penetration is faster into damaged skin than into intact skin. A total of 3,6 % of the dose applied is absorbed percutaneously after a single topical application of 1 g azelaic acid (5g Skinoren acne acne cream). Clinical investigations in acne patients indicated similar absorption rates of azelaic acid from Skinoren gel and cream.A portion of the azelaic acid absorbed through the skin is excreted in unchanged form with the urine. The remaining portion is broken down by ß-oxidation into dicarboxylic acids with shorter chain length (C7, C5) which have likewise been found in the urine.Steady-state plasma levels of azelaic acid in rosacea patients after 8 weeks twice daily treatment with Skinoren gel were double those seen in control patients. However the plasma levels were within the range also observed in volunteers and acne patients on normal diets. This indicates that the extent of percutaneous absorption of azelaic acid following twice daily application of Skinoren gel does not alter the systemic burden of azelaic acid derived from dietary and endogenous sources.Indications:Treatment of mild to moderate acne vulgaris.Treatment of mild to moderate (papulopustular) rosacea.Identification:White to yellowish white opaque hydrogel.Presentation:Standard tubes with membrane closures and screw caps (tube material aluminium, internal coating done with epoxide, end seal band made of polyamide-based compound, external coating made of polyester, screw cap made of high density polyethylene) containing 5g or 30g or 50g.Patient information leaflet:Scheduling status of the medicinal product:Name of the medicinal product:Skinoren gel.Gel.What Skinoren gel is used for:Skinoren gel is used for the treatment of mild to moderate acne vulgaris and mild to moderate (papulopustular) rosacea.Presentation of Skinoren gel:Standard tubes with membrane closures and screw caps (tube material aluminium, internal coating done with epoxide, end sea (band made of polyamide-based compound, external, coating made of polyester, screw cap made of high density polyethylene) containing 5g or 30g or 50g.Identification of Skinoren gel:White to yellowish white opaque hydrogel.

Pack size:
1 Pack

Quantity in pack:
1

Marketing description:
Dermatologicals acne.

Brand:
Skinoren

See more See less

How to use

Usage instructions:
Dosage and directions for use:Skinoren gel should be applied to the affected areas of the skin twice a day (morning and evening) and rubbed in gently. Approximately 0,5 g = 2,5 cm of gel is sufficient for the entire facial area.Before Skinoren gel is applied, the skin should be thoroughly cleaned with plain water, and dried. A mild skin-cleansing agent may be used. It is important to use Skinoren gel continuously over the entire period of treatment.The duration of use of Skinoren gel can vary from person to person and also depends on the severity of the skin disorder. In general, an improvement becomes apparent after about 4 weeks. To obtain the best results, however, Skinoren gel should be used continuously over several months.In the event of intolerable skin irritation (see "side effects"), the amount of gel per application should be reduced or the frequency of use of Skinoren gel should be reduced to once a day until the irritation ceases. If required, the treatment should be temporarily interrupted for a few days.Paediatric population:Used in adolescents (12 to 18 years of age) for the treatment of acne vulgaris. Dose adjustment is not required when Skinoren gel is administered to adolescents (12 to 18 years of age).The safety and efficacy of Skinoren gel for the treatment acne vulgaris in children below the age of 12 years have not been established.The safety and efficacy of Skinoren gel for the treatment of papulopustular rosacea in children below the age of 18 years have not been established.Patient information leaflet:Please read this leaflet carefully before you start using Skinoren gel.Keep this leaflet. You may need to read it again.If you have further questions, please ask your doctor or your pharmacist.Skinoren gel has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours.How to use Skinoren gel:Do not share medicines prescribed for you with others.Skinoren gel should be applied to the affected area of the skin twice a day (morning and evening) and rubbed in gently.Approximately 0.5g = 2.5 cm of gel is sufficient for the entire facial area.Before Skinoren gel is applied, the skin should be thoroughly cleaned with plain water and dried. A mild skin-cleansing agent may be used.It is important to use Skinoren gel continuously over the entire period of treatment.The duration of use of Skinoren gel can vary from person to person and also depends on the severity of the skin disorder. In general, an improvement becomes apparent after about 4 weeks.To obtain the best results, however, Skinoren gel should be used continuously over several months.In the event of intolerable skin irritation (see "side effects"), the amount of gel per application should be reduced or the frequency of use of Skinoren gel should be reduced to once a day until the irritation cases. If required, the treatment should be temporarily interrupted for a few days.Paediatric population:Skinoren gel is used in adolescents (12 to 18 years of age) for the treatment of acne vulgaris. No dose adjustment is required.Safety and efficacy of Skinoren gel for the treatment of acne vulgaris in children below the age of 12 years have not been established.The safety and efficacy of Skinoren gel for the treatment of papulopustular rosacea in children below the age of 18 years have not been established.

Storage instructions:
Keep well closed. Store at or below 25 degrees C.Patient information leaflet:Storing and disposing of Skinoren gel:Keep Skinoren gel out of the reach and sight of children.Store at or below 25 degrees C. Keep well closed.Do not use after the expiry date stated on the pack.Return all unused medicine to your pharmacist for safe disposal.Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets).

Warnings:
Contra-indications:Hypersensitivity to the active substance or to any excipients of the gel.For external use only.Care must be taken when using Skinoren gel to avoid contact with the eyes, mouth and other mucous membrane and patients should be instructed accordingly. In the event of accidental contact, the eyes, mouth and/or affected mucous membrane should be washed with large amounts of water. If eye irritation persists, patients should consult a medical practitioner. The hands should be washed after each application of the Skinoren gel.It is advisable to avoid alcoholic cleansers, tinctures and astringents, abrasives and peeling agents when using Skinoren gel for treatment of papulopustular rosacea.Benzoic acid is mildly irritant to the skin, eyes and mucous membranes. Propylene glycol may cause skin irritation.Interactions:None are known.Pregnancy and lactation:Safety of Skinoren gel in pregnancy and lactation has not been established.Side effects and special precautions:Side effects:Only cutaneous treatment-related adverse events were reported in clinical studies.In clinical studies, most frequently observed side effects included, application site pruritus, application site burning and application site pain.Frequencies of side effects observed in clinical studies and given in the table below are defined according to MedDRA frequency convention: very common (=1/10); common (=1/100, <1/10); uncommon (=1/1000, < 1/100); rare (=1/10 000, < 1/1000).Acne:System organ class - very common - common - uncommon:Skin and subcutaneous tissue disorder - - - - - contact dermatitis.General disorders and administration site conditions - application site pruritus, application site burning, application site pain - application site dryness, application site rash, application site paraesthesia - application site erythema, application site exfoliation, application site warmth, application site discolouration.Rosacea:System organ class - very common - common - uncommon:Skin and subcutaneous tissue disorders - - - - acne, contact dermatitis.General disorders and administration site conditions - application site burning, application site pain, application site pruritus - application site paraesthesia, application site dryness, application site rash, application site oedema - application site discomfort, application site erythema, application site urticaria.Hypersensitivity and rash has been reported in post-marketing surveillance.Worsening of asthma in patients treated with azelaic acid has been reported during post-marketing surveillance.Paediatric population:Treatment of acne vulgaris in adolescents 12 to 18 years of age: in 4 clinical phase II and II/III studies involving adolescents 12 to 17 years of age (120/383; 31%), overall incidence of adverse events for Skinoren gel was similar for the groups aged 12 to 17 years (40%), aged =18 years (37%) and for the entire patient population (38%). This similarity also applied to the group aged 12 to 20 years (40%).Known symptoms of overdosage and particulars of its treatment:Treatment is supportive and symptomatic.Keep out of reach of children.Patient information leaflet:Before using Skinoren gel:Do not use Skinoren gel:If you are hypersensitive to azelaic acid or any ingredients of the gel.Take special care with Skinoren gel:Skinoren gel is for external use only.Care must be taken when using Skinoren gel to avoid contact with the eyes, mouth and other mucous membranes. If it does, the eyes, mouth and/or affected mucous membrane should be washed with large amounts of water. If eye irritation persists, consult your doctor.The hands should be washed after each application of Skinoren gel.It is advisable to avoid alcohol cleanser, tinctures and stringents, abrasives and peeling agents when using Skinoren gel for treatment of papulopustular rosacea.Benzoic acid is irritant to the skin, eyes and mucous membranes.Propylene glycol may cause skin irritation.Pregnancy and breastfeeding:If you are pregnant or breastfeeding your baby while using Skinoren gel, please consult your doctor, pharmacist or other healthcare professional for advice.Safety in pregnancy and breastfeeding has not been established.Using other medicines with Skinoren gel:If you are using other medicines on a regular basis, including complementary or traditional medicines, the use of Skinoren gel with these medicines may cause undesirable interactions.Please consult your doctor, pharmacist or other healthcare professional for advice.There are no interactions so far known for Skinoren gel.If you use more Skinoren gel than you should or if Skinoren gel is taken by mouth:In the event of an overdosage, consult your doctor or pharmacist.If neither is available, rush the patient to the nearest hospital or Poison Control Centre.Possible side effects:Skinoren gel can have side effects.The spectrum of undesirable skin effects related to Skinoren gel was similar in acne and rosacea.Acne:Frequent:Application site pruritus (itchiness).Application site burning.Application site pain.Application site dryness.Application site rash.Application site paraesthesia (sensation of tingling, burning, pricking or numbness).Less frequent:Contact dermatitis (allergic reaction of the skin).Application site erythema (superficial reddening of the skin).Application site exfoliation (peeling off).Application site warmth.Application site discolouration.Rosacea:Frequent:Application site burning.Application site pain.Application site pruritus (itchiness).Application site paraesthesia (sensation of tingling, burning, pricking or numbness).Application site dryness.Application site rash.Application site oedema (swelling).Less frequent:Acne.Contact dermatitis (allergic reaction of the skin).Application site discomfort.Application site erythema (superficial reddening of the skin).Application site urticaria (hives).Worsening of asthma in patients treated with azelaic acid has been reported post-marketing.Not all side effects reported for Skinoren gel are included in this leaflet. Should your general health worsen while using Skinoren gel, please consult your doctor, pharmacist or other healthcare professional for advice.

See more See less

Ingredients

Ingredients:
Azelaic Acid 15% Gel

See more See less